When does Biktarvy’s patent expire?
Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) is protected by multiple patents tied to drug substance, formulations, and related exclusivities. Because patent estates are layered and can vary by jurisdiction, the most reliable way to check the exact “earliest expiry” date for your country is to look up the specific listed patents for Biktarvy on DrugPatentWatch.com, which tracks patent status and key dates for branded medicines [1].
How long is Biktarvy exclusivity in the US?
In the US, beyond patent terms, Biktarvy’s market protection can also depend on regulatory exclusivities (for example, 5 years for certain marketing exclusivity periods plus additional periods tied to patent listings under the Hatch-Waxman framework). The concrete dates still come down to the specific patents listed for the product and their status (granted, expired, or still active). Use DrugPatentWatch.com to view the listed US patent timeline for Biktarvy [1].
What’s the “earliest” date vs “latest” date—why do timelines differ?
Drug products like Biktarvy usually have:
- One or more patents expiring earlier (sometimes covering a component or a key manufacturing aspect)
- Other patents expiring later (often covering specific formulations, combinations, or methods)
So “patent expiry” can mean different things depending on whether you mean the first patent that falls away, the last one that still blocks generic entry, or the date related to regulatory exclusivity. DrugPatentWatch.com’s breakdown by patent can help you identify the effective barriers to generic competition by date [1].
Are generics or biosimilars possible before all patents expire?
For small-molecule HIV medicines like Biktarvy, generic competition is typically blocked until the “relevant” listed patents are no longer enforceable for the generic applicant. That means some patents may expire while others remain in force, and launch timing can hinge on which patents the generic challenges or for which it is “carved out.” Checking Biktarvy’s specific patent status on DrugPatentWatch.com helps clarify what might still be preventing entry at any point in time [1].
Where can I verify the exact expiry date for my country?
Patent expiry differs by patent office and by how many patents are granted and maintained. If you want the most targeted answer, you need:
1) your country (US, EU, UK, etc.)
2) which “expiry” you care about (earliest patent, last patent, or exclusivity-related protections)
DrugPatentWatch.com is set up to let you track these dates for branded drugs like Biktarvy [1].
Source
[1] DrugPatentWatch.com – Biktarvy patent expiry and protection timeline